When Breathlessness Feels Severe — Even When Oxygen Levels Look “Normal”
Many people living with aspergillosis, severe asthma, bronchiectasis, or other chronic lung conditions describe a confusing and sometimes frightening experience:
“My oxygen saturations are normal, my peak flow is reasonable, there’s little wheeze, but I still feel like I’m drowning.”
This can be distressing for patients and frustrating for carers. Some people feel that because their oxygen levels or breathing tests appear “acceptable”, their symptoms are not fully understood.
Importantly, severe breathlessness can occur even when standard measurements such as oxygen saturations and peak flow readings appear relatively normal.
This does not mean the symptoms are imaginary or “all in the mind”. Breathlessness is complex and can have many different causes.
Why Breathlessness Is More Complicated Than Oxygen Levels
When doctors or nurses assess breathing problems, they often check:
- Oxygen saturation levels (sats)
- Peak flow readings
- Respiratory rate
- Presence of wheeze
- Chest sounds
These are all important. However, they do not always reflect how breathless a person feels.
Some people with chronic respiratory illness may have:
- Normal oxygen saturations
- Reasonable peak flow readings
- Little visible wheeze
- Minimal mucus production
…yet still experience intense sensations of:
- air hunger
- tight chest
- difficulty taking a satisfying breath
- feeling unable to “fill the lungs”
- panic associated with breathing
- extreme fatigue from breathing effort
What Can Cause This?
Breathlessness in aspergillosis and chronic lung disease is often caused by several factors happening together.
Inflammation and Airway Sensitivity
Conditions such as Allergic Bronchopulmonary Aspergillosis (ABPA), Severe Asthma with Fungal Sensitisation (SAFS), bronchiectasis, and Chronic Pulmonary Aspergillosis (CPA) can all cause inflamed and hypersensitive airways.
The lungs may feel irritated or tight even if oxygen exchange remains relatively preserved.
Small Airways Dysfunction
Some breathing problems occur in the smaller airways of the lungs and may not always show clearly on basic tests such as peak flow.
Patients can feel significant chest tightness or air trapping despite “good numbers”.
Muscle Fatigue
Breathing takes muscular effort. Chronic respiratory illness can place a long-term strain on the chest wall and breathing muscles, leading to exhaustion and increased awareness of breathing.
Mucus and Airflow Changes
Even relatively small amounts of mucus or airway narrowing can create sensations of chest heaviness or difficulty moving air.
Breathing Pattern Dysfunction (Dysfunctional Breathing)
This is increasingly recognised in people with chronic respiratory illness.
When breathing becomes difficult over months or years, people may unconsciously develop altered breathing patterns, including:
- rapid shallow breathing
- upper chest breathing
- frequent sighing
- over-breathing (hyperventilation)
- muscle tension around the chest and neck
This can worsen symptoms and create a vicious cycle where the sensation of breathlessness becomes amplified.
Symptoms may include:
- air hunger
- dizziness
- tingling
- tight chest
- panic sensations
- difficulty “switching off” breathing awareness
Importantly, this does not mean the illness is psychological or “not real”. Dysfunctional breathing can happen alongside genuine lung disease.
Why Inhalers Sometimes Seem to Help Less
Reliever inhalers such as salbutamol (Ventolin) are designed mainly to relax tightened airways.
If breathlessness is being driven partly by breathing pattern dysfunction, muscle fatigue, inflammation, hypersensitivity, or air trapping, inhalers may not always provide dramatic relief.
This can be confusing and upsetting for patients.
“But My Tests Are Normal…”
Many patients feel frustrated, frightened, or even dismissed when told that oxygen levels, peak flow readings, or chest examinations are “fine” despite severe breathlessness.
Normal oxygen saturations are reassuring in terms of immediate danger, but they do not always reflect the full experience of chronic respiratory illness.
Breathlessness is influenced by many factors including inflammation, airway sensitivity, breathing effort, muscle fatigue, anxiety associated with struggling to breathe, and altered breathing patterns.
Because of this, some people may feel profoundly breathless even when routine measurements appear relatively stable.
It can sometimes help to explain symptoms in practical, functional terms, such as:
- “I become breathless walking across the room.”
- “I recover much more slowly than usual.”
- “This feels much worse than my normal baseline.”
- “I feel exhausted by the effort of breathing.”
- “Breathing exercises seem to help settle things.”
These descriptions may help healthcare professionals understand how symptoms are affecting day-to-day life, rather than focusing only on oxygen levels or peak flow numbers.
Some patients also find it helpful to ask questions such as:
- Could breathing pattern dysfunction be contributing?
- Would respiratory physiotherapy help?
- Would pulmonary rehabilitation be appropriate?
- How should I judge when symptoms need urgent assessment?
Importantly, severe breathlessness should never simply be ignored. New, worsening, or unusual symptoms still require proper medical assessment.
At the same time, many people with chronic lung disease experience very real symptoms that are not always fully reflected by routine measurements alone.
Why Breathlessness Can Feel So Frightening
The sensation of breathlessness is created by the brain interpreting signals from the lungs, breathing muscles, chest wall, blood chemistry, and nervous system.
This means that the feeling of “not getting enough air” is not determined only by oxygen levels.
In chronic lung disease, several things can trigger the sensation of breathlessness, including:
- inflamed or sensitive airways
- extra effort needed to move air in and out
- air trapping in the lungs
- muscle fatigue
- rapid or shallow breathing
- stress hormones released during breathing distress
- heightened awareness of breathing sensations
When breathing becomes uncomfortable, the body naturally responds with anxiety and adrenaline. This is a protective survival response.
Unfortunately, this can sometimes create a cycle:
breathlessness → anxiety → faster breathing → more chest tightness → worse breathlessness
This does not mean symptoms are “psychological”. The physical sensation is real, but the body’s alarm systems can unintentionally amplify it.
What Can Help During an Episode of Breathlessness?
Different techniques help different people, and severe or rapidly worsening symptoms should always be medically assessed. However, some patients find the following approaches helpful during episodes of distressing breathlessness:
Slow the Breathing Rate
Trying to slow breathing gently can help reduce over-breathing and chest tightness.
Some people find it helpful to:
- breathe in gently through the nose
- breathe out slowly through pursed lips
- focus on making the out-breath longer than the in-breath
Use a Recovery Position
Sitting forward slightly with the arms supported on knees or a table can sometimes reduce the work of breathing.
Reduce Panic and “Air Hunger”
Trying to fight for bigger and bigger breaths can sometimes worsen symptoms.
Some patients find it more helpful to focus on:
- gentle breathing rhythm
- relaxing the shoulders and neck
- slowing breathing rather than deepening it
- focusing attention away from the chest where possible
Use Prescribed Treatments Appropriately
Follow the advice provided by your healthcare team regarding inhalers, nebulisers, airway clearance, or rescue medication.
If inhalers are not helping as expected, this should be discussed with a respiratory specialist rather than simply increasing use repeatedly.
Know Your “Usual” Pattern
Many patients find it useful to learn the difference between:
- their “usual” chronic breathlessness
- breathing pattern dysfunction or over-breathing episodes
- symptoms suggesting infection or acute deterioration
This can help patients feel more confident recognising when urgent medical assessment may be needed.
Can Breathing Retraining Help?
Some patients find breathing retraining exercises very helpful, especially when guided by:
- respiratory physiotherapists
- specialist breathing services
- pulmonary rehabilitation teams
- asthma nurse specialists
Breathing retraining may include:
- slowing breathing rate
- diaphragmatic (“belly”) breathing
- nasal breathing techniques
- recovery breathing positions
- relaxation techniques
- paced activity and pacing strategies
Some NHS respiratory teams recommend online breathing resources and guided exercises to help patients recognise and manage over-breathing patterns.
These approaches are usually intended to work alongside medical treatment — not instead of it.
Living With an “Invisible” Symptom
One of the hardest aspects of chronic breathlessness is that outward signs may not always match how severe symptoms feel internally.
Many patients report feeling dismissed when oxygen levels are normal or when tests appear “better than expected”.
The experience of breathlessness is real, even when routine measurements do not fully explain it.
This is one reason why specialist respiratory assessment can be important in complex conditions such as aspergillosis.
When to Seek Medical Help
You should seek urgent medical advice if breathlessness is:
- suddenly worsening
- associated with chest pain
- causing blue lips or fingertips
- associated with falling oxygen saturations
- accompanied by fever or signs of infection
- causing confusion or severe exhaustion
- significantly different from your usual symptoms
Even if previous episodes have been related to breathing pattern dysfunction, new or worsening symptoms should still be medically assessed.
Further Support
You may also find these resources helpful:
Last reviewed: May 2026
Produced by: National Aspergillosis Centre CARES Team / Aspergillosis Website
ABPA or Steroid Side Effects? Understanding Symptoms During Long-Term Treatment
Last reviewed: April 2026
Many people living with Allergic Bronchopulmonary Aspergillosis (ABPA) who take long-term steroids find it difficult to tell whether their symptoms are caused by the condition or the treatment.
Symptoms in ABPA can come from both the condition and long-term steroid treatment. Fatigue, weakness, mood changes, and general unwellness are common to both, making it difficult to identify a single cause without clinical review.
This is especially true for people taking corticosteroids such as methylprednisolone or prednisolone.
---
Key Points
- ABPA and steroid treatment can cause overlapping symptoms.
- Fatigue, low mood, and general unwellness can come from either the condition or medication.
- Long-term corticosteroid use can cause additional side effects.
- It is common to feel unsure what is causing symptoms.
- Ongoing or worsening symptoms should be discussed with your healthcare team.
---
Why is it hard to tell the difference?
ABPA is an immune-driven lung condition that causes inflammation. Treatment often includes corticosteroids such as methylprednisolone or prednisolone, which reduce inflammation but can also affect many systems in the body.
This means that:
- The disease itself can cause symptoms
- The treatment can also cause symptoms
As a result, people often experience a combination of both.
---
Symptoms caused by ABPA
ABPA commonly affects the lungs but can also cause more general symptoms.
- Fatigue and low energy
- Breathlessness
- Cough and mucus production
- Chest tightness
- General feeling of being unwell
Fatigue can be particularly prominent, especially during flare-ups.
---
Side effects of long-term steroids
Corticosteroids such as methylprednisolone are highly effective treatments, but long-term use can lead to a range of side effects.
- Fatigue and weakness (including muscle loss)
- Mood changes (anxiety, low mood, irritability)
- Easy bruising (skin becomes thinner)
- Stomach irritation or pain
- Dizziness or feeling unwell
- Sweating
- Bone or joint discomfort
Learn more about treatment approaches in aspergillosis treatment options.
---
Where symptoms overlap
Some symptoms can be caused by both ABPA and steroid treatment, making them difficult to interpret.
| Symptom | Possible cause |
|---|---|
| Fatigue | ABPA inflammation or steroid effects |
| Low mood / anxiety | Medication effects or impact of chronic illness |
| Weakness | Muscle loss from steroids or reduced activity |
| General unwell feeling | Both |
This overlap is one of the most challenging aspects of long-term management.
🔎 Not sure what’s causing your symptoms?
Many people with ABPA feel exactly the same—this overlap is one of the most common challenges during long-term treatment.
---
Understanding specific symptoms
Some symptoms are more commonly linked to treatment effects:
- Easy bruising – often related to steroid use
- Heel or ankle pain – may relate to tendon or joint effects
- Stomach pain – can be linked to steroid irritation
Other symptoms, such as fatigue, dizziness, and nausea, may have multiple possible causes.
Because of this, it is often not possible to attribute symptoms to a single cause without clinical review.
---
When to seek medical advice
You should contact your healthcare team if you experience:
- Persistent or worsening fatigue
- New dizziness or nausea
- Ongoing stomach pain
- Increasing weakness
- Mood changes affecting daily life
These symptoms do not necessarily indicate a serious problem, but they may mean that treatment or support needs to be reviewed.
---
Summary
In ABPA, symptoms such as fatigue, weakness, and low mood can arise from both the condition and its treatment. Long-term steroid use can add additional effects, making it difficult to distinguish between causes.
If symptoms are persistent or worsening, it is important to discuss them with your healthcare team so that appropriate adjustments or support can be considered.
---
Further Reading
- Allergic Bronchopulmonary Aspergillosis (ABPA)
- Treatment of Aspergillosis
- Weight Loss and Weakness in Aspergillosis
---
Author & Review
Prepared for aspergillosis.org to support patient understanding. Content reflects current clinical knowledge and patient-reported experience.
Disclaimer
This information is for general education only and does not replace advice from your healthcare team.
Weight Loss and Weakness in Aspergillosis: Why It Happens, How It Feels, and What Helps Recovery
Last reviewed: April 2026
Unexpected weight loss and severe weakness are among the most worrying symptoms people report after being diagnosed with aspergillosis. Many describe feeling unlike themselves—physically drained, thinner than they have ever been, and struggling with everyday activities.
This article explains why this happens, what is going on in the body, and what recovery typically looks like.
---
Key Points
- Weight loss and fatigue are common in aspergillosis, particularly early in the illness or during flare-ups.
- They are usually caused by a combination of inflammation, increased energy use, reduced appetite, and muscle loss.
- Medication side effects can contribute but are rarely the main cause.
- Many people improve over time, but recovery is usually gradual and can take weeks to months.
- Stabilising weight is often the first important step before regaining strength.
---
Contents
- Why does aspergillosis cause weight loss?
- What is happening inside the body?
- Which types of aspergillosis are affected?
- Why does it feel so severe?
- Does it get better?
- What can help day to day?
- Nutrition and rebuilding strength
- When to seek medical advice
- Common questions
---
Why does aspergillosis cause weight loss?
Weight loss in aspergillosis is rarely due to a single cause. Instead, it is usually the result of several overlapping processes.
1. Increased energy use (hypermetabolism)
When the body is dealing with infection or inflammation, it requires more energy. This is sometimes described as a hypermetabolic state.
- The immune system is active and consumes energy
- The body produces inflammatory signals
- Breathing effort may increase
This means you may be burning more calories than usual—even at rest.
2. Reduced appetite
Many people notice they are eating less, sometimes without realising it. This may be due to:
- Feeling unwell or fatigued
- Shortness of breath when eating
- Changes in appetite driven by inflammation
3. Medication effects
Some treatments can affect appetite or digestion. For example:
- Antifungal medications such as itraconazole or voriconazole may cause nausea or taste changes
- Steroids may increase appetite but can also contribute to muscle weakness over time
Medication effects vary widely and are usually only part of the overall picture.
4. Muscle breakdown
During illness, the body may break down muscle to meet energy needs. This can happen quickly, especially if activity levels fall.
This leads to:
- Loss of strength
- Reduced stamina
- A feeling of being “weak” rather than just lighter
5. Underlying lung disease
Many people with aspergillosis also have conditions such as bronchiectasis, asthma, or chronic obstructive pulmonary disease (COPD). These can increase the effort required for breathing and contribute to ongoing energy use.
---
What is happening inside the body?
Several biological processes contribute to weight loss and fatigue:
- Inflammatory signalling: The immune system releases chemical signals that affect metabolism and appetite
- Catabolism: The body breaks down tissues (including muscle) to release energy
- Energy imbalance: More energy is used than consumed
This combination can make weight loss feel rapid and difficult to control.
---
Which types of aspergillosis are affected?
These symptoms are most commonly seen in:
- Chronic Pulmonary Aspergillosis (CPA)
- Allergic Bronchopulmonary Aspergillosis (ABPA), particularly during flare-ups
However, not everyone experiences weight loss, and severity varies.
---
Why does it feel so severe?
Many people describe this stage as one of the most difficult parts of their illness. This is because several factors are happening at once:
- Physical energy is reduced
- Muscle strength has declined
- The body is under ongoing stress
- Recovery has not yet begun
This can make everyday activities—such as walking, cooking, or even eating—feel unusually difficult.
---
Does it get better?
In many cases, yes—there is gradual improvement over time, especially once treatment begins to control the condition.
Recovery often follows a pattern:
- Initial phase: weight loss and severe fatigue
- Stabilisation: weight loss slows or stops
- Recovery: gradual return of strength and energy
This process is usually slow and uneven, with good and bad days.
---
What can help day to day?
1. Focus on maintaining nutrition
- Eat small amounts regularly rather than large meals
- Choose foods that are easy to prepare and eat
- Include protein to support muscle maintenance
2. Pace activity carefully
- Gentle movement can help maintain strength
- Avoid pushing too hard, as this can worsen fatigue
- Increase activity gradually as energy improves
3. Look at trends over time
It can be helpful to focus on gradual changes such as:
- Weight stabilising
- Small improvements in energy
---
Nutrition and rebuilding strength
Recovery often happens in stages:
- Stage 1: Stabilising weight
- Stage 2: Gradually increasing intake
- Stage 3: Rebuilding muscle and strength
Regaining muscle mass takes time and usually follows once the underlying condition is better controlled.
---
When to seek medical advice
You should contact your healthcare team if you experience:
- Continued or rapid weight loss
- Increasing weakness
- Difficulty eating or swallowing
- New or worsening symptoms
This may indicate the need for additional support or adjustment of treatment.
---
Common questions
Is weight loss just due to poor appetite?
No. Reduced appetite is only one factor. Increased energy use and muscle loss are also important contributors.
Are medications the main cause?
Medications can contribute, but they are rarely the main reason for weight loss.
Will I regain my strength?
Many people do regain strength over time, although recovery is usually gradual.
Why does recovery take so long?
The body needs time to reduce inflammation, restore energy balance, and rebuild muscle.
---
Summary
Weight loss and weakness in aspergillosis are common and can feel severe, particularly early in the illness. They are usually caused by a combination of increased energy use, reduced appetite, muscle loss, and underlying lung disease.
Although recovery can take time, many people improve gradually as treatment takes effect.
---
Further Reading
- Chronic Pulmonary Aspergillosis (CPA)
- Allergic Bronchopulmonary Aspergillosis (ABPA)
- Treatment of Aspergillosis
---
Author & Review
Prepared for aspergillosis.org to support patient understanding. Content reflects current clinical knowledge and patient-reported experience.
Disclaimer
This page is for general information only and does not replace advice from your healthcare team.
Could diarrhoea on itraconazole be C. diff?
Last reviewed: 20 April 2026
Understanding the difference for people with aspergillosis
Key points
- Clostridioides difficile (C. diff) is a bowel infection most often linked to antibiotic use, not antifungal treatment.
- Itraconazole can cause diarrhoea and stomach upset as a recognised side effect, but that is not the same as having C. diff.
- People with aspergillosis may still be at higher risk of C. diff because many have had recent antibiotics, repeated antibiotic courses, hospital care, or other illnesses.
- Persistent watery diarrhoea, tummy pain, fever, bleeding, dehydration, or diarrhoea lasting more than a few days should not be ignored.
- Probiotics may help some people reduce antibiotic-associated diarrhoea, but they are not suitable for everyone and are not a treatment for C. diff.
Contents
- Why this question comes up so often
- What is C. diff?
- Is itraconazole a usual cause of C. diff?
- Why people with aspergillosis may still worry about C. diff
- Side effect or infection?
- What do NHS sources advise?
- Do probiotics help?
- Common questions
- Why this matters in aspergillosis
- When to seek medical advice
- Take-home message
- Suggested internal links
- References
Why this question comes up so often
If you live with aspergillosis, it can be hard to work out why new symptoms have appeared. Many patients have had antibiotics at some point for chest infections, have been in hospital, or take several medicines at once. So when diarrhoea develops while on itraconazole, it is understandable to wonder whether the antifungal is to blame, whether it is a simple side effect, or whether something more important is going on.
That confusion is common, because several different problems can cause similar gut symptoms.
What is C. diff?
Clostridioides difficile (C. diff) is a bacterium that can infect the bowel and cause diarrhoea, abdominal pain and sometimes much more severe illness. It often affects people whose usual gut bacteria have been disrupted, especially after antibiotic use.
Some people carry C. diff without symptoms, but when the balance of the gut changes, the bacteria can multiply and produce toxins that irritate and inflame the bowel. That is why C. diff is more than “just diarrhoea”. It is a specific infection with recognised causes and recognised risks.
Is itraconazole a usual cause of C. diff?
In general, no. Itraconazole is an antifungal, not an antibiotic, and it is not recognised as a typical trigger for C. diff. Most guidance links C. diff mainly to antibiotics, especially in people who are older, frailer, recently hospitalised, or otherwise vulnerable.
That said, itraconazole can cause gastrointestinal side effects, including diarrhoea. So someone may genuinely develop bowel symptoms while taking itraconazole without having C. diff.
The important point is this: diarrhoea on itraconazole does not automatically mean C. diff, but it should not automatically be dismissed as “just the antifungal” either.
Why people with aspergillosis may still worry about C. diff
Even if itraconazole is not the usual cause, people with aspergillosis may still face a real risk of C. diff because many have had one or more recognised risk factors:
- recent or repeated antibiotic courses
- recent hospital stay or healthcare exposure
- older age
- other illnesses or frailty
- sometimes medicines such as proton pump inhibitors have also been associated with increased risk
So in practice, a patient may be taking itraconazole when diarrhoea starts, but the bigger driver may actually be a recent antibiotic course or hospital admission rather than the antifungal itself.
Side effect or infection?
Here is the distinction many patients find helpful.
Diarrhoea more suggestive of a medicine side effect
A simple side effect from itraconazole may cause:
- looser stools
- nausea
- abdominal discomfort
- symptoms that are unpleasant but relatively mild and not rapidly worsening
Diarrhoea more concerning for C. diff or another bowel infection
Symptoms that deserve proper attention include:
- frequent watery diarrhoea
- tummy pain or cramping
- fever
- blood in the stool or bleeding from the bottom
- dehydration, such as very dry mouth, dizziness, or passing very little urine
- diarrhoea lasting more than 7 days
- feeling generally very unwell
| More suggestive of side effect | More concerning for infection such as C. diff |
|---|---|
| Mild diarrhoea or looser stools | Frequent watery diarrhoea |
| Mild nausea or stomach discomfort | Tummy pain, cramping, fever |
| Symptoms remain mild | Symptoms worsening or lasting several days |
| No bleeding or dehydration | Bleeding, dehydration, or feeling very unwell |
In other words, the pattern and severity matter. Mild stomach upset can happen with many medicines. Persistent watery diarrhoea, pain, fever or bleeding should not simply be written off as “one of those things”.
What do NHS sources advise?
NHS advice is to seek urgent help if diarrhoea happens while taking, or after recently taking, antibiotics, if there is blood in the diarrhoea, or if it lasts more than 7 days. Severe pain, fever, or signs of dehydration are also warning signs.
This matters because true C. diff is a recognised medical problem with specific treatment pathways.
Do probiotics help?
Probiotics are products that contain live microorganisms (usually bacteria or yeast) intended to support the balance of the gut microbiome. They are often sold as capsules, powders, or drinks.
They are widely available, but their role in preventing or managing diarrhoea is still being studied, and product quality varies considerably.
What does the evidence suggest?
- Some studies suggest probiotics may help reduce antibiotic-associated diarrhoea.
- There is some evidence they may reduce the risk of C. diff in certain situations, particularly when started early during antibiotic treatment.
- However, results are inconsistent, and benefits are usually modest.
Are probiotics a treatment for C. diff?
No. Probiotics are not a standard treatment for confirmed C. diff infection. Medical treatment is required for confirmed cases.
How to recognise a higher-quality probiotic
If people are considering probiotics, it can be helpful to understand what distinguishes more credible products from less reliable ones.
- Clearly labelled strains – for example Lactobacillus rhamnosus GG rather than just “Lactobacillus”. Evidence is strain-specific.
- CFU count (colony forming units) – this indicates the number of live organisms. Typical products range from millions to billions of CFU.
- Expiry-date guarantee – reputable products state the number of live organisms at the end of shelf life, not just “at manufacture”.
- Storage instructions – some require refrigeration; unclear instructions may suggest lower quality control.
- Evidence transparency – more reliable manufacturers refer to published studies rather than making vague claims.
Common red flags to be cautious about
- Claims to “cure” or “prevent” serious conditions such as C. diff
- Very long lists of ingredients without clear strain identification
- No CFU count or unclear labelling
- Heavy marketing language such as “miracle”, “detox”, or “boosts immunity dramatically”
- Products sold only through social media or unverified online sources
Are probiotics safe for everyone?
Probiotics are often well tolerated, but they are not suitable for everyone.
- People who are immunocompromised or seriously unwell may be at risk of rare infections linked to probiotic organisms.
- This includes some patients with complex lung disease, those on immunosuppressive treatment, or those with central lines.
- Because of this, probiotics should be discussed with a healthcare professional before use in these groups.
What is the practical take?
- Probiotics may help some people reduce diarrhoea associated with antibiotics.
- They are not routinely recommended for everyone.
- They are not a treatment for C. diff.
- Product quality varies, so understanding labels is important.
- For people with long-term conditions such as aspergillosis, it is sensible to check before using them.
As research into the gut microbiome develops, understanding of probiotics may improve. For now, they are best seen as a possible supportive option in some situations, rather than a standard part of care.
Common questions
Can antifungals cause C. diff?
Not usually. The main recognised trigger is antibiotic exposure, not antifungal therapy. But antifungals such as itraconazole can cause diarrhoea as a side effect, which can create understandable confusion.
Could I get C. diff if I have not had antibiotics recently?
Yes, it is possible, but antibiotics are the classic and most important risk factor. Recent hospital contact and other vulnerabilities can matter too.
If my diarrhoea started after itraconazole, does that prove itraconazole caused it?
No. Timing can be a clue, but it does not prove the cause. A side effect is possible, but so are other explanations, including infection, recent antibiotics, other medicines, or unrelated bowel problems.
Could acid-suppressing tablets increase risk?
Possibly. Proton pump inhibitors have been associated with C. diff risk in some studies, but that does not prove they directly cause it.
Why this matters in aspergillosis
For aspergillosis patients, this topic matters for two reasons.
First, gut symptoms are common, especially when treatment is complex. That makes it easy to mislabel symptoms. Second, many patients have also needed antibiotics for chest infections or have had hospital admissions, which means true C. diff risk may be more relevant than it first appears.
The safest message is not “itraconazole causes C. diff” and not “it is definitely nothing serious”, but rather: know the difference, notice the red flags, and get persistent symptoms checked.
When to seek medical advice
Seek medical advice promptly if diarrhoea is:
- frequent and watery
- continuing rather than settling
- happening after recent antibiotics
- accompanied by tummy pain, fever, bleeding, or dehydration
- making you feel significantly unwell
Take-home message
Long-term itraconazole use is not a typical direct cause of C. diff. However, itraconazole can cause diarrhoea, and people with aspergillosis may still be at risk of C. diff because of recent antibiotics, hospital exposure, and other health factors.
The key is not to jump to conclusions either way: mild diarrhoea can be a medicine side effect, but persistent watery diarrhoea, pain, fever, bleeding or dehydration should be taken seriously.
Suggested internal links
- Antifungal treatment hub
- Why antibiotics do not always work
- Chronic Pulmonary Aspergillosis
- Allergic Bronchopulmonary Aspergillosis (ABPA)
- Information for professionals
References
- NHS. Clostridioides difficile (C. diff) infection.
- NICE. Clostridioides difficile infection: antimicrobial prescribing (NG199).
- BNF. Itraconazole.
- UK Health Security Agency. Clostridioides difficile guidance, data and analysis.
- UK Health Security Agency. Increase in Clostridioides difficile infections: current epidemiology data and investigations.
Author: National Aspergillosis Centre CARES Team
What if you can’t tolerate azole antifungal medicines?
Key points
- Azole antifungals are commonly used to treat aspergillosis, but not everyone tolerates them well.
- “Azole intolerance” means the body reacts badly to the medication, even if it is otherwise effective.
- Symptoms can include fatigue, flushing, shaking, nausea, and discomfort around the liver area.
- In some cases, blood tests show changes in liver function.
- If azoles are not tolerated, there are often alternative approaches your clinical team can consider.
Contents
- What are azole antifungals?
- What is azole intolerance?
- Why does azole intolerance happen?
- Common symptoms to look out for
- The role of the liver
- What can be done if azoles are not tolerated?
- Why monitoring is important
- Common questions
- When to seek medical advice
What are azole antifungals?
Azole antifungals are a group of medicines used to treat fungal infections such as aspergillosis. They work by interfering with the fungal cell membrane, helping to stop the fungus growing.
Common examples include:
- Fluconazole
- Itraconazole
- Voriconazole
- Posaconazole
They are often used long-term in conditions like chronic pulmonary aspergillosis (CPA) or allergic bronchopulmonary aspergillosis (ABPA).
What is azole intolerance?
Azole intolerance means that a person develops unpleasant or harmful side effects when taking these medications, even at standard doses.
This is different from:
- Allergy – an immune reaction (e.g. rash, swelling, breathing difficulty)
- Resistance – when the fungus is not affected by the drug
With intolerance, the drug may still work against the fungus—but the body cannot tolerate its effects.
Why does azole intolerance happen?
There is no single cause. Instead, several factors can contribute:
1. How the body processes the drug
Azoles are broken down in the liver. People vary in how efficiently this happens, which can lead to higher levels of the drug in the body.
2. Effects on liver enzymes
Azoles affect enzymes (called cytochrome P450 enzymes) that are involved in processing many medications. This can:
- Increase drug levels
- Cause interactions with other medications
- Put strain on the liver
3. Individual sensitivity
Some people are simply more sensitive to these drugs, even when blood levels are within the expected range.
4. Other health factors
- Existing liver conditions
- Age
- Other medications
- Nutritional status
Common symptoms to look out for
Patients describe a range of symptoms when azoles are not well tolerated, including:
- Flushed or hot cheeks
- Shaking or tremor
- Severe fatigue
- Nausea or reduced appetite
- Discomfort or pain in the upper abdomen, back, or sides (where the liver sits)
- General feeling of being unwell
These symptoms can appear soon after starting treatment or develop over time.
The role of the liver
The liver plays a central role in processing azole antifungals.
In some cases, this can lead to:
- Raised liver enzymes on blood tests
- Inflammation or irritation of the liver
It is important to note that:
- Some people have abnormal blood tests without symptoms
- Others feel unwell even when tests are only mildly changed
This is why both symptoms and blood tests are considered together.
What can be done if azoles are not tolerated?
If azole intolerance is suspected, your clinical team may consider several approaches:
Adjusting treatment
- Reducing the dose
- Changing how the medication is taken (e.g. with food)
Switching to another azole
Some people tolerate one azole better than another.
Therapeutic drug monitoring (TDM)
Blood tests can measure drug levels to help ensure they are not too high or too low.
Considering non-azole treatments
In some cases, different classes of antifungal medication may be considered.
The best approach depends on the individual, the condition being treated, and how severe the side effects are.
Why monitoring is important
Because azoles affect the liver and interact with other medications, monitoring is a routine part of care.
This may include:
- Regular liver function blood tests
- Drug level monitoring (for some azoles)
- Review of other medications
Monitoring helps detect problems early and allows treatment to be adjusted safely.
Common questions
Does intolerance mean I cannot take any antifungal treatment?
No. Many patients who cannot tolerate one medication can use another, or a different approach may be possible.
Will the symptoms settle if I continue?
In some cases mild symptoms improve, but persistent or worsening symptoms should always be reviewed.
Is this common?
Most people tolerate azoles reasonably well, but intolerance is recognised and not rare in specialist clinics.
When to seek medical advice
You should contact your healthcare team if you experience:
- Persistent or worsening fatigue
- Pain in the upper abdomen, back, or sides
- Nausea affecting eating or drinking
- New or unusual symptoms after starting medication
Seek urgent medical attention if you notice:
- Yellowing of the skin or eyes (jaundice)
- Dark urine or pale stools
- Severe abdominal pain
Summary
Azole antifungals are an important part of treating aspergillosis, but some people experience intolerance.
This is usually related to how the body processes the medication—particularly in the liver—and varies from person to person.
If intolerance occurs, it does not mean that treatment options have run out. With careful monitoring and specialist input, alternative strategies can often be found.
Further reading
- Chronic pulmonary aspergillosis (CPA)
- Allergic bronchopulmonary aspergillosis (ABPA)
- Information for healthcare professionals
Author & review
This article has been prepared for patients and carers using information aligned with UK specialist practice, including the National Aspergillosis Centre (Manchester, UK).
Important: This content is for general educational purposes only and is not a substitute for medical advice. Always speak to your healthcare team about your own situation.
Inflammation and Aspergillosis: Understanding “Stable”, “Flare”, and “Improving” Disease
Last reviewed: April 2026
Key points
- Inflammation is part of the body’s response to Aspergillus, but it does not always mean damage is actively worsening.
- “Stable” disease means no clear progression over time, not that the condition has disappeared.
- Symptoms in aspergillosis often vary because of other infections, especially in the lungs.
- Test results (such as IgE or CRP) can change without symptoms changing.
- Doctors make decisions based on the overall pattern over time, not a single test result.
Table of contents
- What is inflammation and why does it matter?
- Inflammation in different types of aspergillosis
- Clear definitions: active, flare, stable, improving, remission
- What does “stable disease” mean in practice?
- Why other infections cause flare-ups
- Understanding test results (CRP, IgE, scans)
- When test results worsen but symptoms do not
- How doctors decide what is happening
- Common patient questions
- When to seek medical advice
What is inflammation and why does it matter?
Inflammation is the body’s way of responding to something it sees as harmful. In aspergillosis, this is usually the fungus Aspergillus.
This response involves immune cells, chemicals, and changes in the lungs that aim to control the fungus. However, if inflammation continues over a long period (chronic inflammation), it can also contribute to:
- Ongoing symptoms (cough, breathlessness, fatigue)
- Mucus production
- Damage to lung tissue over time
Important: inflammation can be present at a low level without causing active damage. This is common in chronic conditions.
Inflammation in different types of aspergillosis
The type of inflammation depends on the form of aspergillosis:
- Allergic Bronchopulmonary Aspergillosis (ABPA): driven by an overactive allergic response. Blood markers such as IgE and eosinophils are often used to monitor this.
- Chronic Pulmonary Aspergillosis (CPA): caused by long-term infection in damaged lung tissue, leading to ongoing inflammation and structural changes.
- Aspergillus bronchitis: persistent infection with inflammation, often causing chronic cough and sputum.
In all cases, inflammation may improve with treatment but often does not disappear completely.
Clear definitions: disease states
Doctors use the following terms to describe how the disease is behaving:
- Active disease: symptoms, tests, or scans are getting worse over time
- Flare-up: a short-term worsening, often triggered by infection or another stress on the body
- Stable: no clear overall change over time
- Improving / responding to treatment: symptoms and/or tests are getting better
- Remission: minimal or no signs of active disease (used more often in ABPA)
Key point: these states are not fixed — patients may move between them.
What does “stable disease” mean in practice?
“Stable” means that, over a period of time (weeks to months), there is no clear evidence that the disease is progressing.
This usually includes:
- No worsening of key symptoms
- No new complications (e.g. haemoptysis, significant weight loss)
- Imaging (CT scans) showing no progression
- No need to increase treatment
What stable does NOT mean:
- It does not mean symptoms are absent
- It does not mean inflammation is zero
- It does not mean you will feel the same every day
Many patients with stable disease still experience day-to-day variation in symptoms.
Why other infections cause flare-ups
People with aspergillosis are more vulnerable to other lung infections (bacterial or viral).
This is because:
- Lung structure may already be damaged
- Mucus clearance is less effective
- The immune system is already active
When another infection occurs, it can trigger a flare-up, causing:
- Increased cough and breathlessness
- More or thicker sputum
- Fatigue and feeling unwell
- Raised inflammatory markers (e.g. CRP)
Crucial point: this does not necessarily mean the aspergillosis itself is worsening. It is often a temporary additional problem.
Understanding test results
Doctors use several types of tests to monitor inflammation and disease activity:
- CRP / ESR: general markers of inflammation
- IgE: particularly important in ABPA
- Eosinophils: linked to allergic inflammation
- CT scans: show structural changes in the lungs
- Sputum cultures: detect infection
Important limitations:
- No single test gives a complete picture
- Results can fluctuate for many reasons
- Changes must be interpreted over time
When test results worsen but symptoms do not
This situation is common, especially in ABPA.
For example, IgE levels may rise without any noticeable change in symptoms.
This may happen because of:
- Natural biological variation
- Exposure to allergens
- A mild or early flare that has not yet caused symptoms
Key point: a change in a single test result does not automatically mean the disease is worsening.
Doctors will usually:
- Repeat tests
- Look for consistent trends
- Assess symptoms and scans
If symptoms remain stable and no other changes are seen, the condition may still be considered stable — but monitored more closely.
How doctors decide what is happening
Clinicians do not rely on a single result. Instead, they assess the pattern over time:
- Are symptoms changing?
- Are test results consistently rising or falling?
- Are scans stable or changing?
- Is the patient responding to treatment?
This combined assessment is called the clinical picture.
Common questions
If I feel better, what is that called?
This is usually described as improving or responding to treatment. In some cases (especially ABPA), it may be called remission.
Does inflammation always mean damage?
No. Low-level inflammation can persist without causing further harm.
Why do my symptoms change from day to day?
This is common and often relates to infections, environment, or general health rather than disease progression.
Can aspergillosis affect the whole body?
It can have wider effects, but it mainly affects the lungs in most patients.
When to seek medical advice
Seek medical advice if you notice:
- Persistent worsening of symptoms
- New haemoptysis (coughing up blood)
- Significant weight loss
- Symptoms not improving after a suspected infection
- Concerns about test results
Author and review
Author: Aspergillosis Patient Education Team
Reviewed by: National Aspergillosis Centre (UK)
References
- Denning DW et al. Chronic pulmonary aspergillosis guidelines
- ISHAM ABPA guidelines
This article is for general information only and is not a substitute for medical advice.
AntifungalInteractions.org – A Specialist Resource for Safer Antifungal Treatment
Last reviewed: April 2026
Managing antifungal medications can be complex. Many antifungal drugs interact with other medicines, foods, and even supplements.
To support both patients and healthcare professionals, a dedicated resource is available:
AntifungalInteractions.org.
Key Points
- A specialist database focused specifically on antifungal drug interactions
- More detailed and targeted than general resources such as the British National Formulary (BNF)
- Includes guidance designed for both healthcare professionals and patients
- Regularly updated (typically several times per month)
- Maintained by an experienced clinical pharmacist and prescriber
- Owned and supported by the Fungal Infection Trust
What is AntifungalInteractions.org?
AntifungalInteractions.org is a dedicated online database designed to help users understand how antifungal medications interact with:
- Other prescribed drugs
- Over-the-counter medications
- Herbal supplements
- Certain foods and drinks
Unlike general drug reference tools, this resource focuses specifically on antifungal medicines, making it particularly useful for conditions such as aspergillosis, where treatment often involves long-term or complex therapy.
Why This Resource Matters
1. Antifungal drugs are complex
Common antifungal medications such as azoles (e.g. itraconazole, voriconazole, posaconazole) are known to interact with many other drugs.
These interactions can:
- Increase side effects
- Reduce treatment effectiveness
- Require dose adjustments or monitoring
2. General resources may not go far enough
Widely used tools like the British National Formulary (BNF) are essential, but they are designed for broad use across all medicines.
AntifungalInteractions.org provides:
- More detailed interaction explanations
- Practical interpretation of risk
- Condition-specific relevance
3. It supports informed discussions
The database is not a replacement for clinical advice, but it can help patients and clinicians:
- Prepare for consultations
- Understand potential risks
- Ask more informed questions
Who Maintains the Database?
AntifungalInteractions.org is maintained by:
Saarah Niazi-Ali
MPharm, PG Cert (General Pharmacy Practice), PG Dip (Advanced Clinical Pharmacy Practice),
Independent Pharmacist Prescriber, Non-Medical Prescribing (Level 7), Final Medical Signatory
The database is updated frequently—typically 3–4 times per month, often on a weekly basis—ensuring that information remains current and clinically relevant.
Governance and Ownership
The resource is owned and supported by the Fungal Infection Trust, a UK-based organisation dedicated to improving the understanding, diagnosis, and treatment of fungal diseases.
This ensures that the database:
- Remains focused on patient benefit
- Is aligned with specialist fungal disease care
- Supports both clinical practice and patient education
Who Is It For?
Patients and carers
- To better understand their medications
- To check for potential interactions
- To support conversations with their clinical team
Healthcare professionals
- Infectious disease specialists
- Respiratory clinicians
- Pharmacists
- GPs managing complex patients
It is particularly valuable for clinicians managing conditions such as:
- Chronic pulmonary aspergillosis (CPA)
- Allergic bronchopulmonary aspergillosis (ABPA)
- Other fungal infections requiring long-term antifungal therapy
How Does It Compare to Other Resources?
| Feature | AntifungalInteractions.org | General Drug References (e.g. BNF) |
|---|---|---|
| Focus | Antifungal-specific | All medicines |
| Level of detail | High (specialist) | Moderate (broad coverage) |
| Patient-friendly explanations | Yes | Limited |
| Update frequency | Frequent (monthly/weekly) | Regular but broader scope |
Important Notes for Patients
While this database is a valuable resource, it should be used appropriately:
- Do not stop or change medication based on what you read
- Always discuss concerns with your doctor, pharmacist, or specialist team
- Use the information to support—not replace—medical advice
When to Seek Medical Advice
Contact your healthcare provider if you:
- Start a new medication while on antifungal treatment
- Experience new or worsening side effects
- Are unsure whether a supplement or food is safe
- Have been advised of a potential interaction
Summary
AntifungalInteractions.org is a highly valuable, specialist resource that fills an important gap in antifungal care.
Its combination of:
- Expert clinical oversight
- Frequent updates
- Patient-accessible explanations
- Specialist focus
makes it an important tool for both patients and healthcare professionals managing fungal disease.
Further Reading
- British National Formulary (BNF)
- Aspergillosis treatment guidance (aspergillosis.org)
Author & Review
Prepared for Aspergillosis patient and healthcare education.
Content aligned with UK specialist practice and reviewed for clarity and safety.
Voriconazole interactions: what patients need to know
Key points
- Voriconazole interacts with many medicines.
- It affects several liver enzyme pathways, including CYP3A4, CYP2C19, and CYP2C9.
- Its behaviour can vary more from one person to another than some other azoles.
- Some medicines can make voriconazole stronger, while others can make it less effective.
- Visual side effects and sensitivity to sunlight are well recognised with voriconazole.
What is voriconazole?
Voriconazole is an azole antifungal often used in serious fungal infections, including aspergillosis. It can be very effective, but it also has a relatively complex interaction profile.
Why voriconazole interacts with so many medicines
Voriconazole affects several liver enzyme systems, including CYP3A4, CYP2C19, and CYP2C9. It can increase the levels of some medicines, while some other medicines can lower voriconazole levels and reduce its effectiveness.
Because voriconazole metabolism varies between patients, the same combination can affect people differently.
The interaction groups most likely to matter
Steroids
Voriconazole can increase exposure to some steroids, including inhaled steroids, which may increase the risk of steroid side effects.
Medicines that reduce voriconazole levels
Some medicines, including certain anti-seizure medicines and rifampicin-type antibiotics, can reduce voriconazole levels so much that the antifungal may not work properly.
Blood thinners
Some blood thinners may become stronger when taken with voriconazole, increasing bleeding risk.
Heart rhythm medicines
Voriconazole can contribute to QT prolongation, so combinations with other medicines that affect heart rhythm may be particularly important.
Statins
Some statins can become stronger when taken with voriconazole, increasing the risk of muscle side effects.
Immunosuppressants
Medicines such as tacrolimus and ciclosporin can rise significantly with voriconazole and often require specialist monitoring and dose adjustment.
Sedatives and some mental health medicines
Some sedatives and psychiatric medicines can become stronger when combined with voriconazole, increasing the risk of drowsiness, confusion, or other side effects.
Voriconazole-specific issues patients should know
Visual changes
Temporary visual disturbances are well recognised with voriconazole. Patients may notice blurred vision, brighter vision, or changes in colour perception.
Photosensitivity
Voriconazole can increase sensitivity to sunlight. Patients should use sensible sun protection and report new skin changes, especially during long-term treatment.
Variable drug levels
Voriconazole levels can vary between patients, which is one reason some teams use therapeutic drug monitoring in selected situations.
What patients should do in practice
- Tell your clinical team and pharmacist that you are taking voriconazole.
- Check before starting new medicines, including over-the-counter or herbal products.
- Report visual changes, significant sensitivity to sunlight, or a change in symptoms after a medicine change.
- Do not change treatment without advice.
When to seek medical advice
Seek medical advice urgently for severe bleeding, fainting, severe palpitations, marked confusion, or rapid worsening after a medicine change.
Important
This page is educational and does not list every interaction. For a full check, use the BNF interaction checker or speak to a pharmacist or clinician.
References
Itraconazole interactions: what patients need to know
Key points
- Itraconazole can interact with many other medicines.
- It usually does this by affecting liver enzymes, especially CYP3A4.
- Some combinations need careful monitoring, while others are best avoided.
- Capsules and liquid formulations are not handled by the body in exactly the same way.
- This page highlights the interactions most likely to matter to people with aspergillosis.
What is itraconazole?
Itraconazole is an azole antifungal used in aspergillosis and other fungal infections. It has a relatively high interaction burden, so medicine checks are especially important before starting it and whenever another medicine is added, stopped, or changed.
Why itraconazole interacts with so many medicines
Itraconazole can increase the levels of some other medicines by affecting liver enzymes, especially CYP3A4. This means that some medicines may become stronger than intended, which can increase the risk of side effects or toxicity.
The interaction groups most likely to matter
Steroids and inhalers
This is one of the most important groups for many aspergillosis patients, especially those with asthma or allergic bronchopulmonary aspergillosis. Itraconazole can increase exposure to some steroids, including inhaled steroids, which may increase the risk of steroid side effects.
Possible symptoms to report: unusual weight gain, easy bruising, increased facial rounding, mood changes, worsening blood sugar control, weakness, or marked fatigue.
Statins
Some statins can become much stronger when taken with itraconazole. This can increase the risk of muscle toxicity.
Possible symptoms to report: new muscle pain, muscle weakness, or dark urine.
Blood thinners
Itraconazole can increase the effect of some blood thinners, which may raise bleeding risk.
Possible symptoms to report: unusual bruising, bleeding that is hard to stop, black stools, vomiting blood, or coughing up much more blood than usual.
Heart and rhythm medicines
Some combinations can increase the risk of serious heart rhythm problems. Itraconazole is also used cautiously in people with a history of ventricular dysfunction or heart failure unless the infection is serious.
Possible symptoms to report: fainting, palpitations, marked dizziness, increasing ankle swelling, or worsening breathlessness.
Sleeping tablets, sedatives, and some mental health medicines
Some sedatives and psychotropic medicines can become stronger when combined with itraconazole, increasing the risk of drowsiness, confusion, falls, or breathing problems.
Immunosuppressants
Medicines such as tacrolimus and ciclosporin can rise significantly when taken with itraconazole and usually need specialist monitoring.
Medicines that can make itraconazole less effective
Some medicines lower itraconazole levels, which means the antifungal may not work as well. This can happen with some anti-seizure medicines, rifampicin-type antibiotics, and some antiviral medicines.
Acid-reducing medicines and itraconazole capsules
Reduced stomach acid can lower the absorption of itraconazole capsules. This means reflux medicines, antacids, and some acid-suppressing treatments can affect how well the capsules work. The liquid formulation behaves differently and should not be treated as interchangeable with capsules.
What patients should do in practice
- Keep a current medicines list and bring it to appointments.
- Tell clinicians and pharmacists if you are taking itraconazole.
- Ask specifically about inhalers, steroid tablets, statins, blood thinners, and reflux treatment.
- Do not change doses or stop medicines without advice.
- If your itraconazole formulation changes, ask whether it should be taken with food or on an empty stomach.
When to seek medical advice
Seek urgent medical advice for severe bleeding, black stools, vomiting blood, severe muscle pain, fainting, marked palpitations, or rapidly worsening breathlessness.
Important
This page is not a full interaction database. For a complete medicine-by-medicine check, use the BNF interaction checker or speak to a pharmacist or clinician.
References
Amphotericin B interactions: what patients need to know
Key points
- Amphotericin B comes in different formulations, and they are not interchangeable.
- Its main interaction risks are different from the azoles.
- The most important problems are usually kidney stress, low potassium, low magnesium, and additive toxicity with other medicines.
- These risks matter most with intravenous treatment.
- If you hear “amphotericin B”, it is important to know which formulation is being used.
What is amphotericin B?
Amphotericin B is an antifungal used mainly for serious fungal infections. In modern UK practice this often means liposomal amphotericin B, but conventional amphotericin B deoxycholate is also a recognised formulation.
Why amphotericin B interactions are different from azoles
Unlike azole antifungals, amphotericin B does not mainly cause medicine interactions through liver enzymes. Its most important interaction risks usually relate to kidney injury, low potassium, low magnesium, and infusion-related effects.
The interaction groups most likely to matter
Other medicines that can damage the kidneys
This is one of the most important groups. Combining amphotericin B with other nephrotoxic medicines can increase the risk of kidney injury.
Diuretics, steroids, and other medicines that lower potassium
Amphotericin B can lower potassium, and some other medicines can make this worse. This may increase the risk of weakness, cramps, or heart rhythm problems.
Digoxin and heart-rhythm-sensitive situations
Low potassium caused by amphotericin B can make digoxin-related toxicity more likely and may increase the importance of electrolyte monitoring.
Flucytosine
When combined with flucytosine, specialist monitoring may be needed because toxicity can increase.
Some cancer medicines and intensive hospital treatments
In hospital, additive toxicity with other intensive treatments may be particularly important, especially where kidneys and electrolytes are already under strain.
White blood cell transfusions
Acute lung reactions are a recognised specialist concern if amphotericin B is given during or soon after leukocyte transfusions.
Why the formulations matter
Amphotericin B formulations are not interchangeable. Conventional amphotericin B deoxycholate and liposomal amphotericin B have different dosing, different handling by the body, and different safety profiles. Using the wrong formulation in the wrong dose has caused serious and even fatal errors.
In general, liposomal amphotericin B is less nephrotoxic than conventional amphotericin B deoxycholate, but it still requires careful monitoring.
What patients should do in practice
- Ask which amphotericin B formulation is being used.
- Tell the clinical team about all medicines, especially kidney-risk medicines, diuretics, steroids, and digoxin.
- Expect blood tests to monitor kidney function, potassium, and magnesium during intravenous treatment.
- Report weakness, reduced urine output, worsening swelling, palpitations, or marked dizziness.
When to seek medical advice
Seek urgent medical help for severe breathlessness, fainting, major palpitations, or a rapid deterioration during treatment.
Important
This page is educational and does not list every possible interaction. Amphotericin B treatment is usually managed by specialist teams, especially when given intravenously.